FABIO EIJI ARIMURA
Projetos de Pesquisa
Unidades Organizacionais
Instituto do Coração, Hospital das Clínicas, Faculdade de Medicina - Médico
LIM/09 - Laboratório de Pneumologia, Hospital das Clínicas, Faculdade de Medicina
LIM/09 - Laboratório de Pneumologia, Hospital das Clínicas, Faculdade de Medicina
11 resultados
Resultados de Busca
Agora exibindo 1 - 10 de 11
conferenceObject Association Of Sarcoidosis, Monoclonal Gammopathy Of Undetermined Significance And Cardiac Amyloidosis: A Case Report(2017) AMARAL, A. F.; OLIVEIRA, M. R.; ARIMURA, F. E.; NASCIMENTO, E. C. T.; BERNARDI, F. C.; FERNANDES, F.; CARVALHO, C. R. R.; KAIRALLA, R. A.; BALDI, B. G.conferenceObject Peribronchiolar Metaplasia Associated to Interstitial Lung Disease: A Case Report(2022) SANTOS, G. D.; BRIDI, G. D.; SAAVEDRA, N. L. M.; VASCONCELOS, A.; SILVA, N. F.; ALMEIDA, G. C.; NASCIMENTO, E. C. T.; ARIMURA, F. E.; AMARAL, A. F.; BALDI, B. G.; KAIRALLA, R. A.- Concentration of serum vascular endothelial growth factor D and its correlation with functional and clinical variables in patients with lymphangioleiomyomatosis from a Brazilian reference centre(2017) OLIVEIRA, Martina Rodrigues; AMARAL, Alexandre Franco; ARIMURA, Fabio Eiji; FREITAS, Carolina Salim; KAIRALLA, Ronaldo Adib; CARVALHO, Carlos Roberto Ribeiro de; BALDI, Bruno Guedes
conferenceObject High Prevalence of Possible Usual Interstitial Pneumonia Pattern in Chronic Hypersensitivity Pneumonitis at a Brazilian Reference Center(2018) AMARAL, A. F.; SCHUBSKY, J. V.; ARIMURA, F. E.; SAWAMURA, M. V.; BALDI, B. G.; CARVALHO, C. R.conferenceObject ARDS in a Patient Whit Sarcoidosis: A Diagnostic Challenge(2020) SILVA, N. F.; PROVENCI, B.; MARTIN, S. R. San; BEDER, T. N.; COLARES, P. F.; HOLZ, I. M.; SERRA, J. P.; AMARAL, A. F.; ARIMURA, F. E.; BALDI, B. G.; KAIRALLA, R. A.conferenceObject Antisynthetase Syndrome Interstitial Lung Disease Acute Exacerbation Due to Bacterial Infection: Case Report(2018) SOUZA, H. S. Pinto; ASSUNCAO, G. L.; OLIVEIRA FILHO, J. R. Bandeira de; VARGAS, L. Paez; COSTA, F. M. da; OLIVEIRA, M. Rodrigues de; ARIMURA, F. E.; AMARAL, A. F.; BALDI, B. G.; KAIRALLA, R. A.conferenceObject Analysis Of Sarcoidosis Cases Followed At University Of Sao Paulo Medical School Of Brazil(2017) VARGAS, L. Paez; MIRANDA, R. R.; ARIMURA, F. E.; AMARAL, A. F.; OLIVEIRA, M. R.; KAIRALLA, R. A.; CARVALHO, C. R. R.; BALDI, B. G.- Concentration of Serum Vascular Endothelial Growth Factor (VEGF-D) and Its Correlation with Functional and Clinical Parameters in Patients with Lymphangioleiomyomatosis from a Brazilian Reference Center(2019) AMARAL, Alexandre Franco; OLIVEIRA, Martina Rodrigues de; DIAS, Olivia Meira; ARIMURA, Fabio Eiji; FREITAS, Carolina Salim Goncalves; ACENCIO, Milena Marques Pagliarelli; ALVARENGA, Vanessa Adelia de; KAIRALLA, Ronaldo Adib; CARVALHO, Carlos Roberto Ribeiro; BALDI, Bruno Guedes; SCLEROSIS, Tuberous; BALBO, Bruno Eduardo Pedroso; WATANABE, Elieser Hitoshi; SAMORANO, Luciana Paula; ONUCHIC, Luiz Fernando; RIVITTI-MACHADO, Maria Cecilia da Matta; MANREZA, Maria Luiza Giraldes de; CORDEIRO, Mauricio Dener; TAKAHASHI, Patricia; OLIVEIRA, Zilda Najjar Prado deIntroductionSerum vascular endothelial growth factor-D (VEGF-D) is a lymphangiogenic growth factor that is considered a valuable tool in the diagnosis of lymphangioleiomyomatosis (LAM). Previous studies have reported a wide variability in VEGF-D serum levels in LAM patients and it seems to be associated with pulmonary impairment and lymphatic involvement.MethodsWe conducted a cross-sectional study from 2009 to 2017 that evaluated VEGF-D serum levels in a cohort of LAM patients who were never treated with mTOR inhibitors and compared them to healthy age-matched volunteers. Clinical and functional parameters were assessed and correlated with their respective serum VEGF-D levels.ResultsOne hundred and four patients were included in the analysis. Serum VEGF-D levels were higher in LAM patients compared to healthy controls: 796 (404-1588) versus 162 (117-232)pg/mL, respectively (p<0.001). Patients with tuberous sclerosis complex-LAM, TSC-LAM (20%), had higher levels of VEGF-D when compared to patients with sporadic LAM (80%) [1005 (641-2732) vs. 772 (370-1383), p=0.05]. Serum VEGF-D levels were weakly correlated with DLCO (r=-0.26, p=0.001) and lymphatic involvement was more frequent in those with serum VEGF-D levels equal or above 800pg/mL (35% vs. 13%, p=0.02).ConclusionsIn LAM, serum VEGF-D is weakly associated with lung function impairment and strongly associated with lymphatic involvement. VEGF-D is validated for use in Brazilian patients with LAM whose characteristics must be accounted for when evaluating their serum VEGF-D levels.
conferenceObject Follicular Bronchiolitis Mimicking Mycobacterial Infection: Case Report(2018) PESSI, M. D.; OLIVEIRA, M. Rodrigues de; FILHO, R. B.; AMARAL, A. F.; ARIMURA, F. E.; SALES, R.; NASCIMENTO, E.; BALDI, B. G.; KAIRALLA, R. A.conferenceObject Nephrobronchial Fistula and Nephrolithiasis Located in the Lung in a Patient with IgG4-Related Disease(2022) PLENS, G. M.; TATAGIBA, L. S.; BRIDI, G. D.; VASCONCELOS, A. P. de; SILVA, N. F.; ALMEIDA, G. C.; NASCIMENTO, E. T. do; ARIMURA, F. E.; KAWASSAKI, A. M.; AMARAL, A. F.; BALDI, B. G.; KAIRALLA, R. A.